R.F.M. Schapers

1.2k total citations
29 papers, 935 citations indexed

About

R.F.M. Schapers is a scholar working on Surgery, Cancer Research and Oncology. According to data from OpenAlex, R.F.M. Schapers has authored 29 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in R.F.M. Schapers's work include Bladder and Urothelial Cancer Treatments (14 papers), Breast Cancer Treatment Studies (10 papers) and Urinary and Genital Oncology Studies (10 papers). R.F.M. Schapers is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Breast Cancer Treatment Studies (10 papers) and Urinary and Genital Oncology Studies (10 papers). R.F.M. Schapers collaborates with scholars based in Netherlands, United States and Switzerland. R.F.M. Schapers's co-authors include R.P.E. Pauwels, A. W. G. B. SMEETS, P. J. van Diest, Jan P. A. Baak, H.M. Ruitenberg, S.M. Bellot, L. H. M. van Gorp, J. Los, J.W.W. Coebergh and Joep Geraedts and has published in prestigious journals such as Cancer, The Journal of Urology and American Journal Of Pathology.

In The Last Decade

R.F.M. Schapers

29 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.F.M. Schapers Netherlands 16 382 381 363 225 202 29 935
A Zajdela France 12 351 0.9× 169 0.4× 291 0.8× 291 1.3× 129 0.6× 28 788
S. D. Finkelstein United States 16 326 0.9× 171 0.4× 304 0.8× 445 2.0× 219 1.1× 25 982
Gregory F. Sterrett Australia 20 284 0.7× 283 0.7× 329 0.9× 225 1.0× 181 0.9× 44 1.0k
S Humphreys United Kingdom 17 212 0.6× 154 0.4× 351 1.0× 227 1.0× 167 0.8× 35 779
Janez Žgajnar Slovenia 22 467 1.2× 410 1.1× 293 0.8× 410 1.8× 168 0.8× 67 1.2k
Shaheen Zakaria United States 11 393 1.0× 404 1.1× 378 1.0× 327 1.5× 70 0.3× 15 857
Véronique Verrièle France 14 381 1.0× 154 0.4× 400 1.1× 119 0.5× 296 1.5× 35 923
G. Zavagno Italy 17 760 2.0× 458 1.2× 517 1.4× 549 2.4× 146 0.7× 37 1.1k
Marilin Rosa United States 16 281 0.7× 166 0.4× 345 1.0× 347 1.5× 103 0.5× 92 890
Marcia Edelweiss United States 20 484 1.3× 372 1.0× 392 1.1× 484 2.2× 102 0.5× 50 1.1k

Countries citing papers authored by R.F.M. Schapers

Since Specialization
Citations

This map shows the geographic impact of R.F.M. Schapers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.F.M. Schapers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.F.M. Schapers more than expected).

Fields of papers citing papers by R.F.M. Schapers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.F.M. Schapers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.F.M. Schapers. The network helps show where R.F.M. Schapers may publish in the future.

Co-authorship network of co-authors of R.F.M. Schapers

This figure shows the co-authorship network connecting the top 25 collaborators of R.F.M. Schapers. A scholar is included among the top collaborators of R.F.M. Schapers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.F.M. Schapers. R.F.M. Schapers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pepels, Manon J., Carla Wauters, R.F.M. Schapers, et al.. (2013). Is the sentinel lymph node pathology protocol in breast cancer patients associated with the risk of regional recurrence?. European Journal of Surgical Oncology. 39(5). 437–441. 4 indexed citations
2.
Berlo, C.L.H. van, et al.. (2008). Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: A follow-up study after 5 years. European Journal of Surgical Oncology. 35(2). 159–163. 11 indexed citations
3.
Peer, Petronella G.M., Peter Bult, Erik Thunnissen, et al.. (2006). Risk Factors for Non-Sentinel Lymph Node Metastases in Patients with Breast Cancer. The Outcome of a Multi-institutional Study. Annals of Surgical Oncology. 14(1). 181–189. 46 indexed citations
4.
Bult, Peter, R.F.M. Schapers, Jos W. R. Meijer, et al.. (2006). Differences in Sentinel Lymph Node Pathology Protocols Lead to Differences in Surgical Strategy in Breast Cancer Patients. Annals of Surgical Oncology. 13(11). 1466–1473. 18 indexed citations
5.
Louwman, Marieke W.J., M.W.P.M. van Beek, R.F.M. Schapers, et al.. (2005). Long‐term survival of T1 and T2 lymph node‐negative breast cancer patients according to mitotic activity index: A population‐based study. International Journal of Cancer. 118(9). 2310–2314. 11 indexed citations
6.
Berlo, C.L.H. van, et al.. (2003). Ambulatory sentinel node biopsy under local anaesthesia for patients with early breast cancer. European Journal of Surgical Oncology. 29(4). 383–385. 18 indexed citations
7.
Hopman, Anton H. N., M. A. F. Kamps, Ernst‐Jan M. Speel, et al.. (2002). Identification of Chromosome 9 Alterations and p53 Accumulation in Isolated Carcinoma in Situ of the Urinary Bladder versus Carcinoma in Situ Associated with Carcinoma. American Journal Of Pathology. 161(4). 1119–1125. 41 indexed citations
8.
Oosterhuis, J. Wolter, et al.. (2002). Abnormalities detected in metaphase chromosomes in bladder carcinoma: prognostic value and comparison with histopathological factors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 441(2). 187–193. 1 indexed citations
9.
Louwman, Marieke W.J., P. J. van Diest, M.W.P.M. van Beek, et al.. (2002). Trends in Breast Cancer Aggressiveness Before the Introduction of Mass Screening in Southeastern Netherlands 1975–1989. Breast Cancer Research and Treatment. 73(3). 199–206. 7 indexed citations
10.
Oosterhuis, J. Wolter, et al.. (2000). MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer. 88(11). 2598–2605. 41 indexed citations
11.
Post, Piet N., Paul J.M. Kil, M.A. Crommelin, R.F.M. Schapers, & J.W.W. Coebergh. (1998). Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971–1995. European Journal of Cancer. 34(5). 705–709. 53 indexed citations
12.
Bergers, Elisabeth, Jan P. A. Baak, P. J. van Diest, et al.. (1997). Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: Results from the multicenter morphometric mammary carcinoma project (MMMCP). International Journal of Cancer. 74(3). 260–269. 24 indexed citations
13.
Schapers, R.F.M., R.P.E. Pauwels, Juul Wijnen, A. W. G. B. SMEETS, & Fred T. Bosman. (1995). Morphometric grading of transitional cell carcinoma of the urinary bladder. Data Archiving and Networked Services (DANS). 1 indexed citations
14.
Kiemeney, Lambertus A., J.W.W. Coebergh, N.P. Koper, et al.. (1994). Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975–1989. European Journal of Cancer. 30(8). 1134–1137. 37 indexed citations
15.
Schapers, R.F.M., et al.. (1993). Heterogeneity in bladder cancer as detected by conventional chromosome analysis and interphase cytogenetics. Cancer Genetics and Cytogenetics. 70(1). 56–61. 11 indexed citations
16.
Schapers, R.F.M., R.P.E. Pauwels, A. W. G. B. SMEETS, et al.. (1993). Image cytometric DNA analysis in transitional cell carcinoma of the bladder. Cancer. 72(1). 182–189. 28 indexed citations
17.
Schapers, R.F.M., et al.. (1993). Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer. Cancer Genetics and Cytogenetics. 71(1). 97–99. 10 indexed citations
18.
Diest, P. J. van, Jan P. A. Baak, E.C.M. Wisse-Brekelmans, et al.. (1992). Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the Multicenter Morphometric Mammary Carcinoma Project. Human Pathology. 23(6). 603–607. 302 indexed citations
19.
Pauwels, R.P.E., A. W. G. B. SMEETS, R.F.M. Schapers, Joep Geraedts, & F.M.J. Debruyne. (1988). Grading in Superficial Bladder Cancer. (2) Cytogenetic Classification. British Journal of Urology. 61(2). 135–139. 14 indexed citations
20.
Pauwels, R.P.E., R.F.M. Schapers, A. W. G. B. SMEETS, F.M.J. Debruyne, & Joep Geraedts. (1988). Grading in Superficial Bladder Cancer. (1) Morphological Criteria. British Journal of Urology. 61(2). 129–134. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026